Eli Lilly's Profit Surges, 2025 Forecast
This is a Mounjaro news story, published by Yahoo Finance, that relates primarily to Zepbound news.
Mounjaro news
For more Mounjaro news, you can click here:
more Mounjaro newsZepbound news
For more Zepbound news, you can click here:
more Zepbound newsdrug discoveries news
For more drug discoveries news, you can click here:
more drug discoveries newsYahoo Finance news
For more news from Yahoo Finance, you can click here:
more news from Yahoo FinanceAbout the Otherweb
Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
obesity treatment counterpart Zepbound. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest obesity medications news, Mounjaro sales news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
diabetes treatment MounjaroAssociated Press News
•Health
Health
Diabetes and obesity drugs fuel Eli Lilly profit in the final quarter of 2024

82% Informative
Eli Lilly and Co. shares slipped 1% to $ 831.64 Thursday in premarket trading.
Sales of diabetes and obesity treatments Mounjaro and Zepbound are soaring in popularity globally due to the amount of weight people lose while taking the injections.
For 2025 , Lilly expects adjusted earnings to range between $22.50 and $ 24 with revenue falling between $58 and $61 billion .
VR Score
89
Informative language
93
Neutral language
24
Article tone
formal
Language
English
Language complexity
40
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
2
Source diversity
1
Affiliate links
no affiliate links